Package 63187-758-30

{"route": ["ORAL"], "spl_id": "f4311c55-f736-4e0d-a743-0b6fdd1395b2", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0363187758905"], "unii": ["0H73WJJ391"], "rxcui": ["151226"], "spl_set_id": ["57ac12ed-27f0-4f5c-96ae-a7433714b429"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (63187-758-30)", "package_ndc": "63187-758-30", "marketing_start_date": "20161003"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (63187-758-60)", "package_ndc": "63187-758-60", "marketing_start_date": "20161003"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (63187-758-90)", "package_ndc": "63187-758-90", "marketing_start_date": "20161003"}], "brand_name": "Topiramate", "product_id": "63187-758_f4311c55-f736-4e0d-a743-0b6fdd1395b2", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "63187-758", "generic_name": "Topiramate", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20140612", "listing_expiration_date": "20261231"}